Imprivata Expands Authentication Platform to Protect Medical Devices and Remote Access to Patient Information from Hacking

Imprivata Confirm ID provides hospitals with a single, extensible authentication platform for the healthcare enterprise that addresses critical cyber security threats and compliance challenges

LEXINGTON, Mass.--()--Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced expanded capabilities for Imprivata Confirm ID, a comprehensive user identity and two-factor authentication platform for the healthcare enterprise. Imprivata Confirm ID® provides hospitals with a single, centralized platform which offers secure and convenient strong authentication for electronic prescribing of controlled substances (EPCS), remote access, medical device access, and other critical clinical workflows.

“A single, centralized authentication management platform improves security and compliance auditing across the enterprise by enabling better control over how, when, and where users interact with patient records and other sensitive information”

Healthcare is in the midst of a cyber security war with 81 percent of healthcare organizations reporting they have been compromised by a cyber-attack, such as phishing, in the past two years, and only half believing they are adequately prepared for future attacks, according to a 2015 KPMG survey. The U.S. Department of Health and Human Services documented that hackers accessed more than 110 million patient health records in 56 major cybersecurity attacks in 2015. Imprivata Confirm ID enables fast, secure authentication to help safeguard healthcare enterprise workflows against hacking, creating a secure, auditable chain of trust, wherever, whenever, and however users interact with patient records, hospital financial data, and other sensitive information.

“As healthcare goes digital, critical clinical workflows are using simple, sometimes generic user names and passwords to provide access, making patient information easily vulnerable to hacking,” said Omar Hussain, president and CEO of Imprivata. “Imprivata’s commitment to our customers is to provide innovative authentication solutions that are seamlessly integrated into the care delivery process. I’m excited that we are building on the phenomenal success we saw with Imprivata Confirm ID in its first year for EPCS by expanding the platform to medical devices and remote access. Our medical device partnership with Capsule is the first of many to show how we can enable our customers to have one user experience for all of their strong authentication needs.”

With the Capsule SmartLinx Neuron 2 mobile clinical computer, Imprivata Confirm ID now facilitates strong authentication for medical devices to optimize how organizations capture, harness, and unlock the power of patient data. Imprivata will showcase this new integration at HIMSS 2016 (booth #3043). Imprivata Confirm ID also safeguards patient health information and allows hospitals to meet regulatory compliance requirements by improving visibility into user interactions with patient information on medical devices.

Initially launched in February 2015 as a comprehensive secure signing solution for EPCS, Imprivata Confirm ID for EPCS helps providers meet DEA requirements for EPCS while also simplifying e-prescribing workflows for all medications. The expanded Imprivata Confirm ID platform now addresses other emerging cybersecurity issues including remote access, medical device security, and in-process authentication for clinical transactions, for all enterprise users.

Imprivata Confirm ID is user-centric and makes security invisible by replacing passwords with a broad range of innovative and convenient authentication methods including Hands Free Authentication, push token notification, and fingerprint biometrics, which allow users to leverage authentication solutions that best meet existing workflow and regulatory requirements.

“A single, centralized authentication management platform improves security and compliance auditing across the enterprise by enabling better control over how, when, and where users interact with patient records and other sensitive information,” said Aaron Miri, CIO of Walnut Hill Medical Center in Dallas, Texas. “At the same time, giving users fast, convenient authentication options ensures no disruption to workflows and gives providers more time to focus on patient care. Healthcare organizations must place the security of patient information as one of the top technological imperatives. Healthcare CIO’s must use every weapon in their arsenal to protect patient information, and this is especially true of the vulnerable medical devices in the dispersed and mobile clinical environment of care.”

Imprivata will host a webinar titled “Combat Phishing Attacks and Other Security Threats with Strong, Two-factor Authentication for Healthcare” on March 10, 2016 at 2 p.m. EST. To learn more about Imprivata Confirm ID, register for the webinar at: https://pages.imprivata.com/0219-ConfirmID2.0_LP-Register-Now.html.

About Imprivata
Imprivata® (NYSE: IMPR), the healthcare IT security company, provides healthcare organizations globally with a security and identity platform that delivers authentication management, fast access to patient information, secure communications, and positive patient identification. Imprivata enables care providers to securely and efficiently access, communicate, and transact patient health information to address critical compliance and security challenges while improving productivity and the patient experience. For more information, please visit www.imprivata.com.

Contacts

Imprivata
John Hallock, 617-615-7712
jhallock@imprivata.com
or
Kerry Pillion, 781-761-1452
kpillion@imprivata.com

Recent Stories

RSS feed for Imprivata

Imprivata